Prostate Cancer Clinical Trial
Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)
Summary
Dosimetry efficacy of the hydrogel spacer.
Full Description
Single arm study for evaluation of dosimetry following use of a commercially available hydrogel spacer implanted in up to 20 males who underwent radiotherapy treatment for prostate cancer. Study utilized pre and post gel insertion CT images to determine endpoints.
Eligibility Criteria
Inclusion Criteria:
Males
At least 18 years of age
Undergone external beam or brachy radiation therapy with a hydrogel spacer in place
Exclusion Criteria:
Clinical and pathological data are not available
Invasive adenocarcinoma that is extracapsular and demonstrates posterior extension
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Lake Success New York, 11104, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.